The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://sabrinankbb210643.birderswiki.com/1945245/retatrutide_vs_tirzepatide_a_comparative_analysis